Literature DB >> 21607621

Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma.

Canan Cacina1, Sibel Bulgurcuoglu-Kuran, Ahmet Cem Iyibozkurt, Ilhan Yaylim-Eraltan, Bedia Cakmakoglu.   

Abstract

In this study, we aimed to investigate a possible association between the Stromal cell-derived factor-1 (SDF-1) and CXCR4 polymorphisms and the risk of developing endometrial carcinoma. SDF-1 3'A and CXCR4 gene polymorphisms was performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism in 139 healthy individuals and 113 patients with endometrial carcinoma. In our study groups SDF-1 3'A AA genotype frequency was higher in patients that of controls and individuals who had AA genotype showed a 2.6-fold increased risk for endometrial cancer. The carriers of CXCR4 T allele were higher in patients compared with controls and individuals who had TT genotype had a 2.5-fold high risk for endometrial carcinoma. Our finding suggest that there was no significant association between the (SDF-1) and CXCR4 polymorphisms and endometrium cancer risk. Further studies in a larger population are needed to better elucidate the role of (SDF-1) and CXCR4 gene polymorphisms in the risk of endometrial carcinogenesis. To the best of our knowledge, this is the first study to show such an association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607621     DOI: 10.1007/s11033-011-0852-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

Review 1.  Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS.

Authors:  M Locati; P M Murphy
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

2.  CXCL12-3' A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?

Authors:  Ana Coelho; Carmen Calçada; Raquel Catarino; Daniela Pinto; Graça Fonseca; Rui Medeiros
Journal:  Cancer Immunol Immunother       Date:  2005-09-06       Impact factor: 6.968

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Authors:  Takashi Kijima; Gautam Maulik; Patrick C Ma; Elena V Tibaldi; Ross E Turner; Barrett Rollins; Martin Sattler; Bruce E Johnson; Ravi Salgia
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

Review 5.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

6.  Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma.

Authors:  Mahboobeh Razmkhah; Abdul-Rasoul Talei; Mehrnoosh Doroudchi; Tahereh Khalili-Azad; Abbas Ghaderi
Journal:  Cancer Lett       Date:  2004-12-13       Impact factor: 8.679

7.  A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer.

Authors:  Eleftherios Vairaktaris; Antonis Vylliotis; Sofia Spyridonodou; Spyridoula Derka; Stavros Vassiliou; Emeka Nkenke; Christos Yapijakis; Zoe Serefoglou; Friedrich W Neukam; Efstratios Patsouris
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

Review 8.  CXC chemokines in angiogenesis of cancer.

Authors:  Robert M Strieter; John A Belperio; Roderick J Phillips; Michael P Keane
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

9.  CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Authors:  Karen Brajão de Oliveira; Julie Massayo Maeda Oda; Julio Cesar Voltarelli; Thiago Franco Nasser; Mario Augusto Ono; Thiago Cezar Fujita; Tiemi Matsuo; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.

Authors:  Ying-Hock Teng; Te-Hsiung Liu; Hsien-Chun Tseng; Tsung-Te Chung; Chia-Ming Yeh; Yu-Chiung Li; Yu-Hsiang Ou; Long-Yau Lin; Hsiu-Ting Tsai; Shun-Fa Yang
Journal:  Head Neck       Date:  2009-10       Impact factor: 3.147

View more
  10 in total

1.  DNA repair gene variants in endometrial carcinoma.

Authors:  Zeynep Birsu Cincin; Ahmet Cem Iyibozkurt; Sibel Bulgurcuoglu Kuran; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2012-01-22       Impact factor: 3.064

2.  CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.

Authors:  Dan Meng; Yin-Xiang Wu; Vidhi Heerah; Shuang Peng; Meng-di Chu; Yong-Jian Xu; Wei-Ning Xiong; Shu-Yun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

3.  Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Authors:  Ferruh K Işman; Canan Kucukgergin; Selçuk Daşdemir; Bedia Cakmakoglu; Oner Sanli; Sule Seckin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

4.  CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.

Authors:  Alda Losi Guembarovski; Roberta Losi Guembarovski; Bruna Karina Banin Hirata; Glauco Akelinghton Freire Vitiello; Karen Mayumi Suzuki; Mayara Tiemi Enokida; Maria Angelica Ehara Watanabe; Edna Maria Vissoci Reiche
Journal:  Mol Biol Rep       Date:  2018-06-20       Impact factor: 2.316

5.  SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.

Authors:  Feng Pan; Shijie Ma; Weike Cao; Haining Liu; Fengli Chen; Xiaofei Chen; Ruihua Shi
Journal:  Mol Biol Rep       Date:  2013-05-28       Impact factor: 2.316

6.  The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.

Authors:  Ke Zhu; Benchun Jiang; Rong Hu; Ying Yang; Miao Miao; Yingchun Li; Zhuogang Liu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.

Authors:  Ruiwan Chen; Yafei Xu; Xiaojing Du; Na Liu; Yingqin Li; Qingmei He; Linglong Tang; Yanping Mao; Ying Sun; Lei Chen; Jun Ma
Journal:  Onco Targets Ther       Date:  2015-10-08       Impact factor: 4.147

8.  The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants.

Authors:  Xiang Tong; Yao Ma; Huajiang Deng; Xixi Wang; Sitong Liu; Zhipeng Yan; Shifeng Peng; Hong Fan
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

9.  Genetic Polymorphism and Expression of CXCR4 in Breast Cancer.

Authors:  Marina Okuyama Kishima; Karen Brajão de Oliveira; Carolina Batista Ariza; Carlos Eduardo Coral de Oliveira; Roberta Losi Guembarovski; Bruna Karina Banin Hirata; Felipe Campos de Almeida; Glauco Akelinghton Freire Vitiello; Kleber Paiva Trugilo; Alda Fiorina Maria Losi Guembarovski; Walter Jorge Sobrinho; Clodoaldo Zago Campos; Maria Angelica Ehara Watanabe
Journal:  Anal Cell Pathol (Amst)       Date:  2015-10-20       Impact factor: 2.916

Review 10.  CXC motif chemokine receptor 4 gene polymorphism and cancer risk.

Authors:  Yang Wu; Chun Zhang; Weizhang Xu; Jianzhong Zhang; Yuxiao Zheng; Zipeng Lu; Dongfang Liu; Kuirong Jiang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.